Literature DB >> 17714417

Divergent expression of cellular prion protein on blood cells of human and nonhuman primates.

Karel Holada1, Jan Simak, Paul Brown, Jaroslav G Vostal.   

Abstract

BACKGROUND: Four recent transmissions of variant Creutzfeldt-Jakob disease infection by transfusion highlight the need for detailed understanding of blood-related prion pathogenesis. Nonhuman primates are the most relevant models of human prion diseases. STUDY DESIGN AND METHODS: Quantitative flow cytometry with monoclonal antibodies FH11, 3F4, and 6H4 against different parts of the normal cellular form of the prion protein (PrP(C)) was used to evaluate its expression on blood cells of humans, chimpanzees, cynomolgus macaques, rhesus macaques, squirrel monkeys, and microcebe lemurs.
RESULTS: Chimpanzees, rhesus macaques, and squirrel monkeys displayed a much higher quantity of total blood cell membrane PrP(C) than humans, due to a markedly higher expression of PrP(C) on their red blood cells (RBCs). In contrast, cynomolgus macaques and lemurs demonstrated substantially lower levels of membrane PrP(C) due to the lack of significant PrP(C) expression on RBCs and platelets (PLTs). All species displayed PrP(C) on white blood cells (WBCs), with the highest levels found on human cells. Only humans, chimpanzees, and to a lesser degree rhesus macaques expressed PrP(C) on PLTs.
CONCLUSION: If PrP(C) contributes to the propagation or transport of prion infectivity in blood, the differences reported here need to be considered when extrapolating results of transmission studies in primate models to blood and blood components in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714417     DOI: 10.1111/j.1537-2995.2007.01451.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease.

Authors:  Candace K Mathiason; Jeanette Hayes-Klug; Sheila A Hays; Jenny Powers; David A Osborn; Sallie J Dahmes; Karl V Miller; Robert J Warren; Gary L Mason; Glenn C Telling; Alan J Young; Edward A Hoover
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 2.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

3.  Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells.

Authors:  Martin Panigaj; Hana Glier; Marcela Wildova; Karel Holada
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

4.  Development of monoclonal antibodies specific for glycated prion protein.

Authors:  Eva Dvorakova; Marek Prouza; Olga Janouskova; Martin Panigaj; Karel Holada
Journal:  J Toxicol Environ Health A       Date:  2011

5.  Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.

Authors:  Sandra McCutcheon; Jan P M Langeveld; Boon Chin Tan; Andrew C Gill; Christopher de Wolf; Stuart Martin; Lorenzo Gonzalez; James Alibhai; A Richard Alejo Blanco; Lauren Campbell; Nora Hunter; E Fiona Houston
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  Erythrocyte Indices in Creutzfeldt-Jakob Disease Predict Survival Time.

Authors:  Yu Kong; Zhongyun Chen; Jing Zhang; Liyong Wu
Journal:  Front Neurol       Date:  2022-02-14       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.